Exhibit 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING
FIRM
We
hereby consent to the incorporation by reference in the
Prospectus constituting a part
of this Registration Statement on Form
S-3 of VistaGen Therapeutics, Inc. of our report dated June 29, 2020
(which report expresses an unqualified opinion and
includes an explanatory paragraph expressing substantial doubt
about the Company’s ability to continue as a going concern), relating to the
consolidated financial statements of
VistaGen Therapeutics, Inc. appearing in the Company’s Annual Report on Form
10-K for the fiscal year ended March 31, 2020.
We also
consent to the reference to us under the caption “Experts” in
the Prospectus.
/s/ OUM
& CO. LLP
San Francisco, California
March 15, 2021
